Dong Wenguang Vice President, Professor, Chief Physician
Vice President of Shenzhen Huaqiao Hospital and Director of the Oncology Center
Vice Chairman of the Hyperthermia Committee, Radiotherapy Branch, Chinese Medical Doctor Association
Chairman of the Tumor Hyperthermia Committee, Shenzhen Anti-Cancer Association
Vice Chairman of the Patient Education Expert Committee, Shenzhen Anti-Cancer Association
Standing Member of the Tumor Hyperthermia Committee, China Anti-Cancer Association
Standing Member of the National Interventional Minimally Invasive Treatment Committee
Standing Member of the Tumor Hyperthermia Committee, China-Japan Medical Science and Technology Exchange Association
Vice Chairman of the Cancer Rehabilitation and Palliative Care Committee, Shenzhen Anti-Cancer Association
Vice Chairman of the Patient Education Expert Committee, Shenzhen Anti-Cancer Association
Vice President of the 2nd Interventional Medicine Branch, Shenzhen Hospital Association
Standing Member of the Interventional Treatment Committee, Shenzhen Anti-Cancer Association
Honored as Provincial Famous Doctor+Provincial Outstanding Communist Party Member+Provincial Model Worker+Provincial Anti-Epidemic Pioneer
Expert Profile: Dong WenguangThe professor has published ... papers in provincial and national-level journals; national and provincial/ministerial-level research projects, published 10obtained ... national invention patents1patents. He has long been dedicated to research on tumor hyperthermia combined with comprehensive treatment of mid-to-late stage tumors. He has inherited and developed a new model of ‘green treatment’ for cancer, adhering to the principle of ‘minimizing damage to normal human tissue while maximizing the killing of tumor cells,’ combining minimally invasive technology with tumor hyperthermia to provide personalized ‘green’ treatment and precision diagnosis and treatment plans for patients with mid-to-late stage cancer.
Professional Expertise: He employs a new system of tumor hyperthermia combined with minimally invasive precision treatment, and has particularly rich clinical experience in treating lung cancer, liver cancer, gastric cancer, colorectal cancer, breast cancer, head and neck tumors, ovarian cancer, pancreatic cancer, and other malignancies. This approach reduces surgical and chemoradiotherapy side effects, cancer pain, tumor metastasis, and complications, alleviates patient suffering, and prolongs survival.
Major media outlets including Guangdong Television, People’s Daily, Xinhua Net, China Daily, Guangzhou Daily, Southern Metropolis Daily, Yangcheng Evening News, Phoenix News, Xinhua Daily, and Information Times have all conducted extensive coverage.